dilantin
Generic: extended phenytoin sodium
Labeler: viatris specialty llcDrug Facts
Product Profile
Brand Name
dilantin
Generic Name
extended phenytoin sodium
Labeler
viatris specialty llc
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
phenytoin sodium 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
58151-110
Product ID
58151-110_872f23a8-e6a3-4038-922d-0c26fc81d8b3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA084349
Listing Expiration
2026-12-31
Marketing Start
2024-12-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
58151110
Hyphenated Format
58151-110
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dilantin (source: ndc)
Generic Name
extended phenytoin sodium (source: ndc)
Application Number
ANDA084349 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (58151-110-01)
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (58151-110-10)
- 100 BLISTER PACK in 1 CARTON (58151-110-88) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (58151-110-32)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "872f23a8-e6a3-4038-922d-0c26fc81d8b3", "openfda": {"upc": ["0358151118014", "0358151110018"], "unii": ["4182431BJH"], "rxcui": ["855671", "855673", "855869", "855871"], "spl_set_id": ["86dd27d1-9cee-48ae-b55d-e2d2f7dbc593"], "manufacturer_name": ["Viatris Specialty LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (58151-110-01)", "package_ndc": "58151-110-01", "marketing_start_date": "20241206"}, {"sample": false, "description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (58151-110-10)", "package_ndc": "58151-110-10", "marketing_start_date": "20250409"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (58151-110-88) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (58151-110-32)", "package_ndc": "58151-110-88", "marketing_start_date": "20241206"}], "brand_name": "DILANTIN", "product_id": "58151-110_872f23a8-e6a3-4038-922d-0c26fc81d8b3", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "58151-110", "generic_name": "Extended Phenytoin Sodium", "labeler_name": "Viatris Specialty LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DILANTIN", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA084349", "marketing_category": "ANDA", "marketing_start_date": "20241206", "listing_expiration_date": "20261231"}